Development of a Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Completed

Conditions

Cachexia

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00994669
09-150B
5R01CA127971 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The long-term objective of this research is to develop a non-invasive approach for early assessment of which patients are at high risk for future development of skeletal muscle atrophy. The investigators hypothesize that the rate constant for the terminal portion of the isotope decay curve following ingestion of a single oral dose of deuterated-3-methylhistidine (D-3MH) provides an accurate measure of this increased risk and that this rate constant can be measured non-invasively from timed spot urine samples. In addition, the investigators hypothesize that ingestion of a meat-containing meal will stimulate synthesis of skeletal muscle proteins to a greater extent than a non-meat-containing meal.

Enrollment

17 patients

Sex

Male

Ages

30 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • male
  • 30-85 years
  • Body Mass Index (BMI) <30 kg/m2

Exclusion criteria

  • Uncontrolled hypertension
  • Glomerular filtration rate less than 60 mL/min/1.73 m2
  • History of recurrent gastrointestinal bleeding
  • Unable or unwilling to provide informed consent
  • Ongoing anti-coagulant therapy

Trial design

17 participants in 2 patient groups

healthy control male
lung cancer male

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems